Laurens W. Wollersheim, MD, Wilson W

Slides:

Advertisements

Similar presentations

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Advertisements

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Davide Gabbieri, MD, Pascal M

Of mice and men and surgical transcatheter aortic valve insertion

The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation Farzaneh Dastan, Pharm D, Azita Hajhossein Talasaz, Pharm D, BCPS,

An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor Dong Zhao, MD, Chunsheng Wang,

Challenging homografts as the holy grail for aortic valve endocarditis

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Sergey Leontyev, MD, Michael A

Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A

Fate of aortic bioprostheses: An 18-year experience

Marcel Ricklefs, MD, Jasmin S. Hanke, MD, Günes Dogan, MD, L

Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Bigger valve size is not always better

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years Jian Ye, MD, FRCSC, John G. Webb, MD,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation Takashi Kunihara, MD, PhD, Niklas Neumann,

Aortic valve replacement with the biocor PSB stentless xenograft

Early Outcomes with Rapid-deployment vs Stented Biological Valves: A Propensity- match Analysis Anthony Nguyen, MD, MSc, Louis-Mathieu Stevens, MD, PhD,

The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Intrinsic cardiac stem cells are essential for regeneration

Victor van Berkel, MD, PhD

Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: What happens to the aortic root in the long run? Bartosz.

Jessica Forcillo, MD, MSc, Yazan M. Duwayri, MD, William D

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

Hassane Abdallah, MD, Alaae Boutayeb, MD, Gebrine El Khoury, PhD

Bicuspid aortic valve aortopathy: One size fits all?

Long-term results of aortic valve–sparing operations in patients with Marfan syndrome Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.

Hsin-Fang Li, PhD, YingXing Wu, MD, Mansen Wang, PhD, Gary L

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Support Your Specialty

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Innovation and science: The future of valve design

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Tetralogy of Fallot in the Current Era

Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,

The aortic valve–sparing operation

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD

Nilto Carias de Oliveira, MD, Tirone E

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Guidelines should bother us, not comfort us

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

The Sorin Freedom SOLO stentless aortic valve: Technique of implantation and operative results in 109 patients Thierry Aymard, MD, Friedrich Eckstein,

The Mitroflow aortic valve: A past, present, and future illuminated

Hans-Joachim Schäfers, MD

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position Amedeo Anselmi, MD, Erwan Flécher, MD, PhD, Vito Giovanni Ruggieri,

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Thanos Sioris, MD, Tirone E

Presentation transcript:

Stentless vs Stented Aortic Valve Bioprostheses in the Small Aortic Root Laurens W. Wollersheim, MD, Wilson W. Li, MD, Abdullah Kaya, MD, PhD, Berto J. Bouma, MD, PhD, Antoine H. Driessen, MD, Wim J. van Boven, MD, PhD, Jan van der Meulen, MD, Bas A. de Mol, MD, PhD Seminars in Thoracic and Cardiovascular Surgery Volume 28, Issue 2, Pages 390-397 (June 2016) DOI: 10.1053/j.semtcvs.2016.02.012 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Survival. (Color version of figure is available online.) Seminars in Thoracic and Cardiovascular Surgery 2016 28, 390-397DOI: (10.1053/j.semtcvs.2016.02.012) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Cumulative incidence function estimates of aortic valve reoperation and structural valve deterioration. SVD, structural valve deterioration. (Color version of figure is available online.) Seminars in Thoracic and Cardiovascular Surgery 2016 28, 390-397DOI: (10.1053/j.semtcvs.2016.02.012) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Mixed effects model of echocardiographic results. MF, Mitroflow; Pmax, maximum valvular gradient; Pmean, mean valvular gradient; SOLO, Freedom SOLO. (Color version of figure is available online.) Seminars in Thoracic and Cardiovascular Surgery 2016 28, 390-397DOI: (10.1053/j.semtcvs.2016.02.012) Copyright © 2016 The Authors Terms and Conditions

Mixed effects model of echocardiographic results of the peak valvular gradient. Seminars in Thoracic and Cardiovascular Surgery 2016 28, 390-397DOI: (10.1053/j.semtcvs.2016.02.012) Copyright © 2016 The Authors Terms and Conditions